White Matter Disease clinical trials at University of California Health
1 research study open to eligible people
open to all eligible people
This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations
Our lead scientists for White Matter Disease research studies include Joseph Gleeson.